Research Progress on Sendai Virus against Tumors

doi:10.3969/j.issn.1674-5817.2014.06.019

Abstract

Abstract: Sendai virus is one of the common pathogens in laboratory rats and mice. Transplanted tumors may be inhibited by type I interferon induction, immune response regulation and directly apoptosis in cancer cells after Sendai virus infection in hosts. Nowadays, Sendai virus has already been gradually developed as an effective and new anti-cancer reagent. In this review, the mechanisms of Sendai virus infection against cancer growth and interference on experiment were described.

Key words: Sendai virus(SeV), Cancer, Interferon, Immune regulation, Apoptosis

CLC Number:

R-332
Q95-33

ZHANG Quan, ZHU Hui-xia, LI Ling-yu, TAN Hai-ming, XUE Zheng-feng. Research Progress on Sendai Virus against Tumors[J]. Laboratory Animal and Comparative Medicine, 2014, 34(6): 515-518.

References

[1] 袁立军, 李晓眠, 李梅. 仙台病毒基因结构与功能的研究进展[J]. 中国病原生物学杂志, 2006, 1(6):462-464.
[2] 隋丽华, 范薇, 杨敬, 等. 实验动物微生物、寄生虫抽样调查及分析[J]. 实验动物与比较医学, 2008, 28(4):259-262.
[3] 魏晓峰, 胡建华, 高诚. 仙台病毒核蛋白的原核表达及鉴定[J]. 中国动物传染病学报, 2010, 18(4):32-36.
[4] Kawaguchi Y, Miyamoto Y, Inoue T, et al.Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle[J]. Int J Cancer, 2009, 124(10):2478-2487.
[5] Zhang Q, Yuan WF, Zhai GQ, et al.Inactivated Sendai Virus Suppresses Murine Melanoma Growth by Inducing Host Immune Responses and Down-regulating β-catenin Expression[J]. Biomed Environ Sci, 2012, 25(5):509-516.
[6] Kimura T, Nakamura H, Koyama S, et al.In vivo gene transfer into the mouse uterus: a powerful tool for investigating implantation physiology[J]. J Reprod Immunol, 2005, 67(1-2):13-20.
[7] Matsuda M, Yamamoto T, Matsumura A, et al.Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope[J]. Gene Ther, 2009, 16(12):1465-1476.
[8] Kondo Y, Fushikida K, Fujieda T, et al.Efficient delivery of antibody into living cells using a novel HVJ envelope vector system[J]. J Immunol Methods, 2008, 332(1-2):10-17.
[9] Kaneda Y, Nakajima T, Nishikawa T, et al.Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system[J]. Mol Ther, 2002, 6(2):219-226.
[10] Kaneda Y.Virosome: a novel vector to enable multi-modal strategies for cancer therapy[J]. Adv Drug Deliv Rev, 2012,64(8):730-738.
[11] Fujihara A, Kurooka M, Miki T, et al.Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation[J]. Cancer Immunol Immunother,2008, 57(1):73-84.
[12] Zhang Q, Wang Z, Yuan Y, et al.Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine[J]. Vet Immunol Immunopathol, 2011, 141(1-2):116-123.
[13] Yoneyama Y, Ueda Y, Akutsu Y, et al.Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells[J]. Biochem Biophys Res Commun, 2007, 355(1):129-135.
[14] Kurooka M, Kaneda Y.Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells[J]. Cancer Res, 2007, 67(1):227-236.
[15] Suzuki H, Kurooka M, Hiroaki Y, et al.Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner[J]. FEBS Lett, 2008, 582(9):1325-1329.
[16] Shibata S, Okano S, Yonemitsu Y, et al.Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene[J]. J Immunol, 2006, 177(6):3564-3576.
[17] Tanaka M, Shimbo T, Kikuchi Y, et al.Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon[J]. Int J Cancer, 2010, 126(8):1982-1991.
[18] Kaneda Y, Kiyohara E, Itai T, et al.Gene Therapy of Melanoma Using Inactivated Sendai Virus Envelope Vector (HVJ-E) with Intrinsic Anti-Tumor Activities: InTech, 2011.
[19] Zhang Q, Xu X, Yuan Y, et al.IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus[J]. Int J Cancer, 2014, 134(1):224-234.
[20] Gao H, Xu XS, Chen ZD, et al.Inactivated Sendai virus induces apoptosis in murine melanoma cells by IGF-1R down-regulation[J].Biomed Environ Sci, 2012, 26(12):998-1002.
[21] Samani AA, Yakar S, LeRoith D, et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights[J]. Endocr Rev, 2007, 28(1):20-47.
[22] Karasic TB, Hei TK, Ivanov VN.Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma[J]. Exp Cell Res, 2010, 316(12):1994-2007.
[23] Kawano H, Komaba S, Kanamori T, et al.A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy[J]. BMC Med, 2007, 5:28.
[24] Takehara Y, Satoh T, Nishizawa A, et al.Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma[J]. Clin Immunol, 2013, 149(1):1-10.